Axa Venture Partners led the $12m second close of a $22m round for AI-equipped sales intelligence platform developer Cognism.

George Health Enterprises and its subsidiary George Medicines have raised a combined $35m in funding from investors including Bupa Australia to drive pipeline development and commercialisation.

George Health Enterprises and its subsidiary George Medicines have raised a combined $35m in funding from investors including Bupa Australia to drive pipeline development and commercialisation.

CapitalG co-led a series C round for Everlaw, developer of a legal information search product, which has now secured more than $96m in total.

Bristol-Meyers Squibb participated in the $78.5m round, which will be used to push Silverback Therapeutics' lead cancer drug candidate towards clinical trials.

The Marcus & Millichap and Axel Springer-backed rental real estate portal has completed its series D round to bring its overall equity funding to more than $150m.

Juniper Networks, Intel and IBM returned for a round led by Dell Technologies Capital that took the application development platform's total funding to $77m.

The cancer immunotherapy developer has closed a $23.6m round featuring 3SBio Group and Eisai, both of which have signed collaboration agreements with it in recent months.

Optum Ventures and Heritage Provider Network reinvested as the healthcare expertise platform increased its overall funding to $40m with a series C round led by Deerfield Managment.

Rocket Internet-backed Goodlord has taken its total funding past $22m having raised more than $12.4m in a round led by venture firm Finch Capital.